Cumberland Pharmaceuticals Inc. (CPIX) financial statements (2020 and earlier)

Company profile

Business Address 2525 WEST END AVENUE
NASHVILLE,, TN 37203
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27365050535555
Cash and cash equivalents27284535384041
Short-term investments 8516151514
Receivables8887665
Inventory, net of allowances, customer advances and progress billings101275466
Inventory101275466
Prepaid expense and other current assets1
Deferred tax assets   343
Other current assets2      
Other undisclosed current assets233311 
Total current assets:49596966677169
Noncurrent Assets
Inventory, Noncurrent15      
Property, plant and equipment1110111
Intangible assets, net (including goodwill)32342122212215
Goodwill11     
Intangible assets, net (excluding goodwill)31342122212215
Deferred costs 2   2 
Other noncurrent assets632222 
Prepaid expense and other noncurrent assets1
Deferred tax assets, net0003111
Other undisclosed noncurrent assets 13   (2) 
Total noncurrent assets:54542528252519
TOTAL ASSETS:1041139393929588
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities828181512159
Accounts payable81198332
Accrued liabilities 179710116
Employee-related liabilities     11
Other liabilities13    21
Other undisclosed current liabilities     (3)(2)
Total current liabilities:2128181512148
Noncurrent Liabilities
Long-term debt and lease obligation20201042  
Long-term debt, excluding current maturities20201042  
Liabilities, other than long-term debt 921111
Other liabilities 921111
Other undisclosed noncurrent liabilities11      
Total noncurrent liabilities:3129125311
Total liabilities:5257292015158
Stockholders' equity
Stockholders' equity attributable to parent, including:52566473778179
Common stock50      
Retained earnings251219201916
Other undisclosed stockholders' equity attributable to parent 515255576263
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Total stockholders' equity:52566473778179
TOTAL LIABILITIES AND EQUITY:1041139393929588

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues4741221132
Revenue, net4133343732
Cost of revenue
(Cost of Goods and Services Sold)
(9)(7)(7)(6)(5)(6)(6)
Gross profit:3933(6)(4)(4)(5)26
Operating expenses(43)(41)(38)(29)(27)(28)(30)
Other undisclosed operating income  403133371
Operating income (loss):(5)(7)(4)(1)14(4)
Nonoperating income
(Investment Income, Nonoperating)
0100000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes     (0) 
Income (loss) from continuing operations before income taxes:(5)(7)(4)(1)14(4)
Income tax expense (benefit)0(0)(4)0(1)(1)2
Net income (loss):(5)(7)(8)(1)12(2)
Net income attributable to noncontrolling interest0000000
Net income (loss) available to common stockholders, diluted:(5)(7)(8)(1)12(2)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(5)(7)(8)(1)12(2)
Other undisclosed comprehensive income000000 
Comprehensive income (loss):(5)(7)(8)(1)12(2)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest000000(0)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)(0)(0)(0)(0)0
Comprehensive income (loss), net of tax, attributable to parent:(5)(7)(8)(1)12(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: